These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

820 related articles for article (PubMed ID: 28468832)

  • 21. Modeling cardiovascular disease in the zebrafish.
    Chico TJ; Ingham PW; Crossman DC
    Trends Cardiovasc Med; 2008 May; 18(4):150-5. PubMed ID: 18555188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The zebrafish as a novel tool for cardiovascular drug discovery.
    Rocke J; Lees J; Packham I; Chico T
    Recent Pat Cardiovasc Drug Discov; 2009 Jan; 4(1):1-5. PubMed ID: 19149699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Multi-organ whole-genome measurements and reverse engineering to uncover gene networks underlying complex traits.
    Tegnér J; Skogsberg J; Björkegren J
    J Lipid Res; 2007 Feb; 48(2):267-77. PubMed ID: 17142807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sortilin and Its Multiple Roles in Cardiovascular and Metabolic Diseases.
    Goettsch C; Kjolby M; Aikawa E
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):19-25. PubMed ID: 29191923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drosophila, genetic screens, and cardiac function.
    Wolf MJ; Rockman HA
    Circ Res; 2011 Sep; 109(7):794-806. PubMed ID: 21921272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling human hematopoietic and cardiovascular diseases in zebrafish.
    North TE; Zon LI
    Dev Dyn; 2003 Nov; 228(3):568-83. PubMed ID: 14579393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Overview of Zebrafish Modeling Methods in Drug Discovery and Development.
    Larijani B; Hamidpour SK; Tayanloo-Beik A; Shahbazbadr A; Yavari H; Namazi N; Biglar M; Arjmand B
    Adv Exp Med Biol; 2022; 1387():145-169. PubMed ID: 34961915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Building a zebrafish toolkit for investigating the pathobiology of epilepsy and identifying new treatments for epileptic seizures.
    Cunliffe VT
    J Neurosci Methods; 2016 Feb; 260():91-5. PubMed ID: 26219659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Essential techniques for introducing medaka to a zebrafish laboratory--towards the combined use of medaka and zebrafish for further genetic dissection of the function of the vertebrate genome.
    Porazinski SR; Wang H; Furutani-Seiki M
    Methods Mol Biol; 2011; 770():211-41. PubMed ID: 21805266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virtual screening and zebrafish models in tandem, for drug discovery and development.
    Hernández-Silva D; Alcaraz-Pérez F; Pérez-Sánchez H; Cayuela ML
    Expert Opin Drug Discov; 2023; 18(8):903-915. PubMed ID: 36383405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spotlight on zebrafish: the next wave of translational research.
    Patton EE; Tobin DM
    Dis Model Mech; 2019 Mar; 12(3):. PubMed ID: 30858282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Navigating the Future of Cardiovascular Drug Development-Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference.
    Povsic TJ; Scott R; Mahaffey KW; Blaustein R; Edelberg JM; Lefkowitz MP; Solomon SD; Fox JC; Healy KE; Khakoo AY; Losordo DW; Malik FI; Monia BP; Montgomery RL; Riesmeyer J; Schwartz GG; Zelenkofske SL; Wu JC; Wasserman SM; Roe MT
    Cardiovasc Drugs Ther; 2017 Aug; 31(4):445-458. PubMed ID: 28735360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transgenic zebrafish models of neurodegenerative diseases.
    Sager JJ; Bai Q; Burton EA
    Brain Struct Funct; 2010 Mar; 214(2-3):285-302. PubMed ID: 20162303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospects of personalized medicine in cardiovascular diseases.
    Lenfant C
    Metabolism; 2013 Jan; 62 Suppl 1():S6-10. PubMed ID: 22999711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using zebrafish models of leukemia to streamline drug screening and discovery.
    Deveau AP; Bentley VL; Berman JN
    Exp Hematol; 2017 Jan; 45():1-9. PubMed ID: 27720937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The emerging use of zebrafish to model metabolic disease.
    Seth A; Stemple DL; Barroso I
    Dis Model Mech; 2013 Sep; 6(5):1080-8. PubMed ID: 24046387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug discovery in a multidimensional world: systems, patterns, and networks.
    Dudley JT; Schadt E; Sirota M; Butte AJ; Ashley E
    J Cardiovasc Transl Res; 2010 Oct; 3(5):438-47. PubMed ID: 20677029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simple animal models for amyotrophic lateral sclerosis drug discovery.
    Patten SA; Parker JA; Wen XY; Drapeau P
    Expert Opin Drug Discov; 2016 Aug; 11(8):797-804. PubMed ID: 27249162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Biochemistry, Physiology and Pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo.
    Van De Craen B; Declerck PJ; Gils A
    Thromb Res; 2012 Oct; 130(4):576-85. PubMed ID: 22801256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Function-driven discovery of disease genes in zebrafish using an integrated genomics big data resource.
    Shim H; Kim JH; Kim CY; Hwang S; Kim H; Yang S; Lee JE; Lee I
    Nucleic Acids Res; 2016 Nov; 44(20):9611-9623. PubMed ID: 27903883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.